Literature DB >> 31112493

Association of Herpes Simplex Virus Testing with Hospital Length of Stay for Infants ≤60 Days of Age Undergoing Evaluation for Meningitis.

Paul L Aronson1, Andrea T Cruz2, Stephen B Freedman3, Fran Balamuth4,5, Kendra L Grether-Jones6, Todd W Lyons7, Alesia H Fleming8, Jeffrey Louie9, Rakesh D Mistry10, Aris C Garro11, Samir S Shah12,13, Lise E Nigrovic7.   

Abstract

Although neonatal herpes simplex virus (HSV) causes significant morbidity, utilization of the cerebrospinal fluid (CSF) HSV polymerase chain reaction (PCR) test remains variable. Our objective was to examine the association of CSF HSV PCR testing with length of stay (LOS) in a 20-center retrospective cohort of hospitalized infants aged ≤60 days undergoing evaluation for meningitis after adjustment for patient-level factors and clustering by center. Of 20,496 eligible infants, 7,399 (36.1%) had a CSF HSV PCR test performed, and 46 (0.6% of those tested) had a positive test. Infants who had a CSF HSV PCR test performed had a 23% longer hospital LOS (incident rate ratio 1.23; 95% CI: 1.14-1.33). Targeted CSF HSV PCR testing may mitigate the impact on LOS for low-risk infants.

Entities:  

Year:  2019        PMID: 31112493      PMCID: PMC6686736          DOI: 10.12788/jhm.3202

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  11 in total

1.  Testing and Empiric Treatment for Neonatal Herpes Simplex Virus: Challenges and Opportunities for Improving the Value of Care.

Authors:  Laura Brower; Amanda Schondelmeyer; Paria Wilson; Samir S Shah
Journal:  Hosp Pediatr       Date:  2016-01-01

2.  Febrile infants with urinary tract infections at very low risk for adverse events and bacteremia.

Authors:  David Schnadower; Nathan Kuppermann; Charles G Macias; Stephen B Freedman; Marc N Baskin; Paul Ishimine; Camille Scribner; Pamela Okada; Heather Beach; Blake Bulloch; Dewesh Agrawal; Mary Saunders; Donna M Sutherland; Mercedes M Blackstone; Amit Sarnaik; Julie McManemy; Alison Brent; Jonathan Bennett; Jennifer M Plymale; Patrick Solari; Deborah J Mann; Peter S Dayan
Journal:  Pediatrics       Date:  2010-11-22       Impact factor: 7.124

3.  In defense of empiric acyclovir therapy in certain neonates.

Authors:  Sarah S Long
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

4.  When should you initiate acyclovir therapy in a neonate?

Authors:  David W Kimberlin
Journal:  J Pediatr       Date:  2008-08       Impact factor: 4.406

5.  Herpes Simplex Virus Infection in Infants Undergoing Meningitis Evaluation.

Authors:  Andrea T Cruz; Stephen B Freedman; Dina M Kulik; Pamela J Okada; Alesia H Fleming; Rakesh D Mistry; Joanna E Thomson; David Schnadower; Joseph L Arms; Prashant Mahajan; Aris C Garro; Christopher M Pruitt; Fran Balamuth; Neil G Uspal; Paul L Aronson; Todd W Lyons; Amy D Thompson; Sarah J Curtis; Paul T Ishimine; Suzanne M Schmidt; Stuart A Bradin; Kendra L Grether-Jones; Aaron S Miller; Jeffrey Louie; Samir S Shah; Lise E Nigrovic
Journal:  Pediatrics       Date:  2018-01-03       Impact factor: 7.124

6.  Herpes simplex virus testing and hospital length of stay in neonates and young infants.

Authors:  Samir S Shah; Jessica Volk; Zeinab Mohamad; Richard L Hodinka; Joseph J Zorc
Journal:  J Pediatr       Date:  2010-02-10       Impact factor: 4.406

7.  Delayed acyclovir therapy and death among neonates with herpes simplex virus infection.

Authors:  Samir S Shah; Paul L Aronson; Zeinab Mohamad; Scott A Lorch
Journal:  Pediatrics       Date:  2011-11-28       Impact factor: 7.124

8.  Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger.

Authors:  Prashant Mahajan; Nathan Kuppermann; Asuncion Mejias; Nicolas Suarez; Damien Chaussabel; T Charles Casper; Bennett Smith; Elizabeth R Alpern; Jennifer Anders; Shireen M Atabaki; Jonathan E Bennett; Stephen Blumberg; Bema Bonsu; Dominic Borgialli; Anne Brayer; Lorin Browne; Daniel M Cohen; Ellen F Crain; Andrea T Cruz; Peter S Dayan; Rajender Gattu; Richard Greenberg; John D Hoyle; David M Jaffe; Deborah A Levine; Kathleen Lillis; James G Linakis; Jared Muenzer; Lise E Nigrovic; Elizabeth C Powell; Alexander J Rogers; Genie Roosevelt; Richard M Ruddy; Mary Saunders; Michael G Tunik; Leah Tzimenatos; Melissa Vitale; J Michael Dean; Octavio Ramilo
Journal:  JAMA       Date:  2016 Aug 23-30       Impact factor: 56.272

9.  Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L M Frenkel; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

10.  The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates.

Authors:  A Chantal Caviness; Gail J Demmler; Yvette Almendarez; B J Selwyn
Journal:  J Pediatr       Date:  2008-04-03       Impact factor: 4.406

View more
  1 in total

1.  Evaluation for Neonatal HSV in Infants Undergoing Workup for Serious Bacterial Infection: A 5-Year Retrospective Review.

Authors:  Laura H Brower; Paria M Wilson; Eileen Murtagh-Kurowski; Joshua D Courter; Samir S Shah; Amanda C Schondelmeyer
Journal:  Hosp Pediatr       Date:  2020-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.